Premium
PHASE II FIL‐PTCL13 STUDY OF ROMIDEPSIN‐CHOEP FOLLOWED BY HIGH‐DOSE CHEMOTHERAPY AND TRANSPLANTATION IN UNTREATED PERIPHERAL T‐CELL LYMPHOMAS
Author(s) -
Chiappella A.,
Carniti C.,
Evangelista A.,
Re A.,
Cabras M.G.,
Stefoni V.,
Castellino C.,
Congiu A.G.,
Pinto A.,
Zanni M.,
Rusconi C.,
Molinari A.L.,
Ciancia R.,
Baldini L.,
Nassi L.,
Re F.,
Tani M.,
Ilariucci F.,
Cavallo F.,
Santoro A.,
Volpetti S.,
Dodero A.,
Pileri S.A.,
Ciccone G.,
Corradini P.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.3_2632
Subject(s) - romidepsin , medicine , vincristine , anaplastic large cell lymphoma , etoposide , transplantation , autologous stem cell transplantation , oncology , surgery , gastroenterology , lymphoma , chemotherapy , cyclophosphamide , histone deacetylase , biochemistry , chemistry , gene , histone
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom